S Caltabiano

640 total citations
28 papers, 536 citations indexed

About

S Caltabiano is a scholar working on Molecular Biology, Nephrology and Social Psychology. According to data from OpenAlex, S Caltabiano has authored 28 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 5 papers in Social Psychology. Recurrent topics in S Caltabiano's work include Erythropoietin and Anemia Treatment (5 papers), Neuroendocrine regulation and behavior (5 papers) and Electrolyte and hormonal disorders (5 papers). S Caltabiano is often cited by papers focused on Erythropoietin and Anemia Treatment (5 papers), Neuroendocrine regulation and behavior (5 papers) and Electrolyte and hormonal disorders (5 papers). S Caltabiano collaborates with scholars based in United States, United Kingdom and India. S Caltabiano's co-authors include Harvey J. Kliman, Michael Feinman, Jerome F. Strauss, Lee-Chuan Kao, Jerome F. Strauss, Samuel Wu, Brendan M. Johnson, Lewis B. Kinter, Alexander R. Cobitz and Katsutoshi Hara and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Medicinal Chemistry and Developmental Biology.

In The Last Decade

S Caltabiano

25 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Caltabiano United States 12 130 128 128 95 86 28 536
M.C. D’Alessio Italy 10 75 0.6× 138 1.1× 90 0.7× 86 0.9× 29 0.3× 15 437
Longjiang Shao United States 16 26 0.2× 405 3.2× 68 0.5× 103 1.1× 199 2.3× 24 834
Abha Aggarwal United States 9 36 0.3× 93 0.7× 40 0.3× 67 0.7× 34 0.4× 15 355
H Rivera United States 11 30 0.2× 403 3.1× 15 0.1× 37 0.4× 24 0.3× 21 664
Nada Starčević Čizmarević Croatia 14 120 0.9× 120 0.9× 26 0.2× 85 0.9× 23 0.3× 37 539
Olga Zhdanova Russia 9 14 0.1× 402 3.1× 17 0.1× 77 0.8× 63 0.7× 30 675
Darijana Horvat United States 15 10 0.1× 172 1.3× 261 2.0× 131 1.4× 24 0.3× 27 581
David Maldonado‐Pérez United Kingdom 11 8 0.1× 119 0.9× 62 0.5× 196 2.1× 29 0.3× 14 421
Shuichi Miyaura Japan 10 30 0.2× 198 1.5× 25 0.2× 50 0.5× 47 0.5× 23 465
Tatsuo Shinagawa United States 10 9 0.1× 209 1.6× 65 0.5× 51 0.5× 34 0.4× 15 455

Countries citing papers authored by S Caltabiano

Since Specialization
Citations

This map shows the geographic impact of S Caltabiano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Caltabiano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Caltabiano more than expected).

Fields of papers citing papers by S Caltabiano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Caltabiano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Caltabiano. The network helps show where S Caltabiano may publish in the future.

Co-authorship network of co-authors of S Caltabiano

This figure shows the co-authorship network connecting the top 25 collaborators of S Caltabiano. A scholar is included among the top collaborators of S Caltabiano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Caltabiano. S Caltabiano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrews, Susan, et al.. (2022). Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function. Clinical Pharmacology in Drug Development. 11(5). 562–575. 5 indexed citations
2.
3.
Caltabiano, S, et al.. (2019). Effect of renal function and dialysis modality on daprodustat and predominant metabolite exposure. Clinical Kidney Journal. 12(5). 693–701. 16 indexed citations
4.
5.
6.
Hara, Katsutoshi, et al.. (2015). Pharmacokinetics, pharmacodynamics and safety of single, oral doses of GSK1278863, a novel HIF-prolyl hydroxylase inhibitor, in healthy Japanese and Caucasian subjects. Drug Metabolism and Pharmacokinetics. 30(6). 410–418. 36 indexed citations
7.
Fossler, Michael J., et al.. (2015). Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women. Clinical Therapeutics. 37(7). 1541–1554. 3 indexed citations
8.
Johnson, Brendan M., et al.. (2013). Effect of food and gemfibrozil on the pharmacokinetics of the novel prolyl hydroxylase inhibitor GSK1278863. Clinical Pharmacology in Drug Development. 3(2). 109–117. 39 indexed citations
9.
10.
Martinez, Diana, Osama Mawlawi, Dah‐Ren Hwang, et al.. (2000). Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: preliminary analyses. Nuclear Medicine and Biology. 27(5). 523–527. 20 indexed citations
11.
Caltabiano, S, et al.. (1999). The integrin specificity of human recombinant osteopontin. Biochemical Pharmacology. 58(10). 1567–1578. 23 indexed citations
12.
Kinter, Lewis B., S Caltabiano, & William F. Huffman. (1993). Anomalous antidiuretic activity of antidiuretic hormone antagonists. Biochemical Pharmacology. 45(9). 1731–1737. 16 indexed citations
13.
Caltabiano, S & Lewis B. Kinter. (1991). Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.. Journal of Pharmacology and Experimental Therapeutics. 258(3). 1046–1054. 5 indexed citations
14.
Uyehara, Catherine, S Caltabiano, Lewis B. Kinter, & M. Gellai. (1989). Noncyclic vasopressin analogs are effective diuretics in conscious rats.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 1128–1133. 1 indexed citations
15.
Caltabiano, S, et al.. (1988). 1-beta mercapto-beta beta-cyclopentamethylenepropionic acid 2-O methyltyrosine-8-arginine vasopressin. Drugs of the Future. 13(1). 25–25. 4 indexed citations
16.
Kao, Lee-Chuan, S Caltabiano, Samuel Wu, Jerome F. Strauss, & Harvey J. Kliman. (1988). The human villous cytotrophoblast: Interactions with extracellular matrix proteins, endocrine function, and cytoplasmic differentiation in the absence of syncytium formation. Developmental Biology. 130(2). 693–702. 116 indexed citations
17.
Caltabiano, S, et al.. (1987). In vitro inhibition of gastric acid secretion by vasopressin. European Journal of Pharmacology. 139(3). 281–286. 7 indexed citations
18.
Caltabiano, S & Bruno Grassi. (1956). [The effect of work, smoking and exposure to cold on blood coagulation].. PubMed. 28(9). 755–76. 1 indexed citations
19.
Caltabiano, S, et al.. (1953). [Para-hydroxypropiophenone and experimental arteriosclerosis].. PubMed. 25(11). 831–47. 1 indexed citations
20.
Ferri, F. & S Caltabiano. (1952). [Myocardial metabolism and dysthyreoses].. PubMed. 5(5). 567–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. D’Alessio Breakdown of academic impact, for papers by Longjiang Shao Breakdown of academic impact, for papers by Abha Aggarwal Breakdown of academic impact, for papers by H Rivera Breakdown of academic impact, for papers by Nada Starčević Čizmarević Breakdown of academic impact, for papers by Olga Zhdanova Breakdown of academic impact, for papers by Darijana Horvat Breakdown of academic impact, for papers by David Maldonado‐Pérez Breakdown of academic impact, for papers by Shuichi Miyaura Breakdown of academic impact, for papers by Tatsuo Shinagawa
Rankless by CCL
2026